Your Notifications
All done, no notifications

What is Lennox-Gastaut Syndrome?

Lennox-Gastaut Syndrome is a developmental and epileptic encephalopathy that usually begins during early childhood. It is characterised by multiple seizure types, particularly tonic, atonic, and atypical absence seizures, along with characteristic EEG findings such as slow spike-and-wave discharges and generalised paroxysmal fast activity. Many patients also experience developmental, cognitive, behavioural, or learning difficulties.

What is the Importance of Timely Treatment?

Timely treatment helps identify the cause of the patient's condition, classify the seizure type, reduce seizure frequency, prevent injury, and support cognitive function and daily skills. Specialist diagnosis should be especially timely in patients with severe, frequent seizure disorders which cannot be managed easily, are associated with falls, or are accompanied by developmental irregularities.

What are the Common Symptoms of Lennox-Gastaut Syndrome?

  • Tonic Seizures: Sudden stiffening of the muscles, which may occur particularly during sleep.
  • Atonic Seizures: Sudden loss of muscle tone that can cause head drops or falls.
  • Atypical Absence Seizures: Episodes of reduced awareness that may begin and end gradually.
  • Myoclonic Seizures: Brief, sudden muscle jerks that may affect one or more parts of the body.
  • Developmental or Learning Difficulties: Cognitive and developmental challenges may occur or become more evident over time.
  • Behavioural Changes: The condition may be accompanied by attention, communication, mood, or behavioural difficulties.

Causes and Risk Factors of Lennox-Gastaut Syndrome

Causes

  • Brain Developmental Abnormalities: Structural brain abnormalities can contribute to LGS.
  • Genetic Conditions: Genetic variants and chromosomal abnormalities may be associated with LGS.
  • Brain Injury: Hypoxic-ischemic injury, birth-related brain injury, or previous neurological damage may contribute.
  • Central Nervous System Infections: Conditions such as encephalitis or meningitis may cause brain injury associated with LGS.
  • Tuberous Sclerosis Complex: Certain neurocutaneous disorders can be associated with LGS.
  • Metabolic Disorders: Some metabolic or mitochondrial disorders may contribute to epileptic encephalopathy.
  • Unknown Cause: In some patients, detailed evaluation cannot identify a specific underlying cause.

Risk Factors

  • Early-Onset Epilepsy: Severe epilepsy beginning in infancy or early childhood may increase the risk.
  • Structural Brain Abnormalities: Developmental or acquired brain lesions can increase susceptibility.
  • Genetic Disorders: Certain genetic conditions may predispose children to severe epilepsy.
  • Previous Brain Injury: Significant neurological injury can contribute to epileptic encephalopathy.
  • CNS Infections: Previous serious infections affecting the brain may increase risk.
  • Neurocutaneous Disorders: Conditions such as tuberous sclerosis can be associated with LGS.

Latest Research and Technologies in the Treatment of Lennox-Gastaut Syndrome in the United Arab Emirates

  • In the United Arab Emirates, multidisciplinary and advanced approaches to the management of Lennox-Gastaut syndrome (LGS), a severe developmental and epileptic encephalopathy characterised by multiple seizure types and treatment resistance. For drug-resistant cases, specialised epilepsy centres may consider vagus nerve stimulation, corpus callosotomy, or resective surgery when a suitable seizure focus is identified. Ongoing research is exploring precision medicine, genetic testing, neuromodulation, advanced seizure monitoring, and individualised treatment strategies to improve seizure control, development, and quality of life.

Treatment options for Dravet Syndrome

Vagus Nerve Stimulation : VNS may be considered for some patients with drug-resistant epilepsy.


Cost Start From 35000Explore Options

Corpus Callosotomy : This palliative procedure may be considered for selected patients with severe drop attacks.

Epilepsy treatment : Patients with a clearly identified focal brain abnormality may undergo specialist surgical evaluation for potentially resective treatment.

Neuromodulation: Selected patients may be evaluated for advanced neuromodulation approaches when conventional treatments are insufficient.

  • Clinical assessment:
    • Seizure History: Detailed assessment of seizure type, frequency, duration, triggers, and response to treatment.
    • Developmental Assessment: Evaluation of cognitive, language, motor, and developmental abilities.
    • Neurological Examination: Assessment of muscle strength, coordination, reflexes, movement, and neurological function.
    • Behavioural Assessment: Evaluation of attention, behaviour, communication, and emotional functioning.
    • Medication Review: Assessment of previous antiseizure medicines and treatment response.
    • Functional Assessment: Evaluation of mobility, daily activities, learning, and independence.
    • Video EEG: Helps characterise seizures and identify the characteristic EEG patterns associated with LGS.
    • Sleep EEG: May help assess sleep-related seizure activity and characteristic electrical abnormalities.
  • Imaging Tests:
    • Brain MRI: MRI helps identify structural abnormalities, developmental malformations, tumors, or previous brain injury.
    • PET and SPECT: Used selectively, especially during presurgical evaluation; they are not routinely required for every patient.
    • EEG-fMRI: This specialised technique can help investigate brain networks involved in epileptic activity and may support complex epilepsy evaluation.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Lennox-Gastaut Syndrome patients in the United Arab Emirates. These services include:

  • Depending on individual needs, they may include physiotherapy, occupational therapy, speech and language therapy, developmental support, behavioural interventions, nutritional support, and educational assistance.
  • Medicines are a major component of LGS management and are usually selected according to seizure type and individual response. Treatment may include antiseizure medicines where clinically appropriate. Many patients need more than one medicine, and an epilepsy specialist should closely monitor treatment.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Dravet Syndrome in United Arab Emirates

Zulekha Hospital Dubai: Top Doctors, and Reviews
Zulekha Hospital Dubai

Dubai, United Arab Emirates

  • A highly skilled multidisciplinary medical staff supports patients through the hospital's advanced diagnostic capabilities, joint replacement surgeries, cardiac catheterisation, neonatal intensive care, and specialised cancer care and rehabilitation services. The hospital uses the latest technology and is internationally accredited for providing quality healthcare based on scientific evidence, providing safe, high-quality care to patients, providing individualised treatment plans, and providing services to international patients.
Message Us
Zulekha Hospital Sharjah: Top Doctors, and Reviews
Zulekha Hospital Sharjah

Sharjah, United Arab Emirates

  • A highly skilled multidisciplinary medical staff supports patients through the hospital's advanced diagnostic capabilities, joint replacement surgeries, cardiac catheterisation, neonatal intensive care, and specialised cancer care and rehabilitation services. The hospital uses the latest technology and is internationally accredited for providing quality healthcare based on scientific evidence, delivering safe, high-quality care to patients, offering individualised treatment plans, and serving international patients.
Message Us
Thumbay University Hospital, Ajman: Top Doctors, and Reviews
Thumbay University Hospital, Ajman

Ajman, United Arab Emirates

Thumbay University Hospital, Ajman located in Ajman, United Arab Emirates is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The hospital has a 250 bed capacity.
  • Excellent quality of healthcare facilities and services at par with developed countries.
  • Multilingual and multinational healthcare professionals working in the Thumbay Hospital Ajman (belonging to 20 nations and fluent in 50 plus languages).
  • Equipped with the newest facilities to ensure highest standards of healthcare delivery to patients at economical costs.
  • Dedicated, compassionate and highly educated healthcare professionals work in Thumbay Hospital Ajman.
  • Well developed diagnostic facilities are also available.
  • A 24/7 functioning emergency care department and advanced facilities in Radiology.
  • There is presence of an ultramodern Catheterization Lab (Cath Lab) and Electrosurgery Cryotherapy in dermatology, Interlocking intramedullary nailing.
  • Also available under dental departments Panoramic, digital intra-oral X-rays, Cephalogram are present.
  • Some of the important specialties in Thumbay Hospital Ajman are:
    • Ear, nose, and throat
    • Cardiovascular
    • Bariatric surgery
    • General surgery
    • Urology
    • Nephrology

Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Lennox-Gastaut Syndrome Treatment?

  • Experienced Epilepsy Specialists: the United Arab Emirates has pediatric neurologists, epileptologists, neurosurgeons, neurophysiologists, and rehabilitation specialists experienced in managing complex epilepsy.
  • Advanced Epilepsy Diagnostics: Leading centres may offer prolonged video-EEG, epilepsy-protocol MRI, PET, SPECT, and specialised presurgical evaluation.
  • Comprehensive Treatment Options: Eligible patients may have access to multiple antiseizure medicines, dietary therapies, neuromodulation, and epilepsy surgery.
  • Multidisciplinary Care: Neurology, neurosurgery, genetics, rehabilitation, nutrition, psychology, and developmental specialists can assess complex LGS cases.
  • Personalised Treatment: Treatment plans are tailored to seizure types, underlying cause, age, developmental status, and previous treatment response.
  • Long-Term Rehabilitation: Patients can receive therapy focused on mobility, communication, development, education, and independence.
  • International Patient Support: Many UAE hospitals provide international patient services including treatment coordination, appointments, travel assistance, accommodation support, and follow-up.

Frequently Asked Questions

LGS is generally a lifelong neurological condition, not one with a fixed recovery period. Treatment aims to reduce seizures, prevent complications, and support development and daily functioning over the long term.

Numerous people with LGS can walk, but issues that arise from seizures like atonic and tonic seizures, developmental problems, muscle weakness, or stability concerns can impact the ability to walk. Physical therapy or proper seizure management can help improve mobility.

Yes. Leading epilepsy centres in the United Arab Emirates may offer long-term video-EEG, advanced MRI, PET, SPECT, genetic testing, presurgical epilepsy evaluation, neuromodulation, and specialised epilepsy surgery facilities.

Many major UAE hospitals have international patient departments that assist with medical appointments, treatment coordination, travel arrangements, accommodation, interpretation, and follow-up care.

Consider the doctor's experience treating drug-resistant epilepsy and LGS, access to video-EEG and advanced imaging, multidisciplinary epilepsy services, dietary therapy and neuromodulation, surgical expertise, rehabilitation, and long-term follow-up.

There is no single success rate for LGS because treatment response varies according to seizure type, underlying cause, age, developmental status, and previous treatment. The main goals are meaningful seizure reduction, injury prevention, and improved quality of life.

the United Arab Emirates has experienced pediatric neurologists, epileptologists, neurophysiologists, neurosurgeons, genetic specialists, and rehabilitation professionals who manage complex and drug-resistant epilepsy.

Risks depend on the treatment used. Antiseizure medicines may cause side effects such as drowsiness or behavioural and metabolic effects, while dietary therapy, VNS, or surgery have their own treatment-specific risks. Specialist monitoring is important.

LGS itself is not an injury. If a seizure causes a fall or injury, protect the person from further harm, place them in a safe position when possible, do not restrain them or place anything in their mouth, and seek emergency care for prolonged seizures, repeated seizures without recovery, serious injury, breathing problems, or a first seizure.

LGS does not usually cause skeletal deformities directly. However, severe developmental impairment, recurrent falls, reduced mobility, or associated neurological problems may contribute to long-term physical limitations in some individuals.

Yes. Frequent seizures, cognitive or developmental difficulties, behavioural problems, injuries, medication effects, and the need for continuous supervision can significantly affect education, independence, family life, and overall quality of life.

Poorly controlled LGS can result in recurrent seizures, seizure-related injuries, developmental and cognitive difficulties, behavioural challenges, reduced independence, and persistent functional limitations. Ongoing specialist care is important.

LGS cannot always be prevented because it can result from genetic, developmental, structural, metabolic, or unknown causes. Appropriate management of conditions that can affect brain development and prompt evaluation of early childhood seizures may help identify epilepsy earlier.

LGS primarily develops in young children and is more likely in individuals with severe early-onset epilepsy, developmental brain abnormalities, genetic disorders, previous brain injury, certain infections, or neurocutaneous conditions. In some patients, clinicians do not identify an underlying cause.

Author

Nimra Haseeb
Nimra Haseeb

MSc Biochemistry

4 Years of Experience

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making. View More

Reviewer

Dr Sonal Gupta
Dr Sonal Gupta

Neurosurgeon

29 Years of Experience

Dr. Sonal Gupta has an experienced neurosurgeon with more than 29+ years of clinical expertise. She is currently the Director, Neuro & Spine Surgery at Fortis Hospital, Shalimar Bagh. Before joining Fortis, she has been associated with various organizations such as Maharaja Agrasen Hospital, Action Balaji Hospital, and Max Hospital. View More

Last Reviewed - January 2026